SK10382002A3 - Substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiv alebo diagnostík, a liečivo, ktoré ich obsahuje - Google Patents

Substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiv alebo diagnostík, a liečivo, ktoré ich obsahuje Download PDF

Info

Publication number
SK10382002A3
SK10382002A3 SK1038-2002A SK10382002A SK10382002A3 SK 10382002 A3 SK10382002 A3 SK 10382002A3 SK 10382002 A SK10382002 A SK 10382002A SK 10382002 A3 SK10382002 A3 SK 10382002A3
Authority
SK
Slovakia
Prior art keywords
group
hydrogen
atom
alkyl
medicament
Prior art date
Application number
SK1038-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Andreas Weichert
Udo Albus
Hans-Willi Jansen
Heinz-Werner Kleemann
Hans-Jochen Lang
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of SK10382002A3 publication Critical patent/SK10382002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK1038-2002A 2000-01-19 2001-01-08 Substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiv alebo diagnostík, a liečivo, ktoré ich obsahuje SK10382002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10001879A DE10001879A1 (de) 2000-01-19 2000-01-19 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2001/000137 WO2001053256A1 (de) 2000-01-19 2001-01-08 Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Publications (1)

Publication Number Publication Date
SK10382002A3 true SK10382002A3 (sk) 2003-04-01

Family

ID=7627855

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1038-2002A SK10382002A3 (sk) 2000-01-19 2001-01-08 Substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiv alebo diagnostík, a liečivo, ktoré ich obsahuje

Country Status (27)

Country Link
US (1) US6703411B2 (hu)
EP (1) EP1259481B1 (hu)
JP (1) JP4880849B2 (hu)
KR (1) KR100726701B1 (hu)
CN (1) CN1184196C (hu)
AR (1) AR027237A1 (hu)
AT (1) ATE530518T1 (hu)
AU (1) AU780466B2 (hu)
BR (1) BR0107660A (hu)
CA (1) CA2397531A1 (hu)
CZ (1) CZ20022465A3 (hu)
DE (1) DE10001879A1 (hu)
EE (1) EE200200381A (hu)
HK (1) HK1051853A1 (hu)
HR (1) HRP20020592A2 (hu)
HU (1) HUP0204095A3 (hu)
IL (1) IL150740A0 (hu)
MX (1) MXPA02006431A (hu)
NO (1) NO20023383L (hu)
NZ (1) NZ520213A (hu)
PL (1) PL356589A1 (hu)
RU (1) RU2267486C2 (hu)
SK (1) SK10382002A3 (hu)
TW (1) TWI240718B (hu)
WO (1) WO2001053256A1 (hu)
YU (1) YU52202A (hu)
ZA (1) ZA200205696B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204989A1 (de) * 2002-02-07 2003-08-21 Aventis Pharma Gmbh Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US20050124666A1 (en) 2003-11-13 2005-06-09 Aventis Pharma Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2689058B2 (ja) * 1992-11-02 1997-12-10 新日本製鐵株式会社 塗装体の乾燥・焼付装置
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE19529612A1 (de) 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19608161A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19624178A1 (de) 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
IL150740A0 (en) 2003-02-12
HUP0204095A2 (hu) 2003-04-28
HK1051853A1 (en) 2003-08-22
HUP0204095A3 (en) 2005-05-30
AU2373201A (en) 2001-07-31
WO2001053256A1 (de) 2001-07-26
NZ520213A (en) 2004-08-27
KR20020073175A (ko) 2002-09-19
BR0107660A (pt) 2002-11-19
KR100726701B1 (ko) 2007-06-13
AU780466B2 (en) 2005-03-24
RU2002122089A (ru) 2004-01-10
HRP20020592A2 (en) 2004-08-31
CA2397531A1 (en) 2001-07-26
EP1259481A1 (de) 2002-11-27
DE10001879A1 (de) 2001-07-19
PL356589A1 (en) 2004-06-28
CN1184196C (zh) 2005-01-12
EE200200381A (et) 2003-12-15
ZA200205696B (en) 2003-11-26
EP1259481B1 (de) 2011-10-26
US20010016596A1 (en) 2001-08-23
ATE530518T1 (de) 2011-11-15
JP4880849B2 (ja) 2012-02-22
TWI240718B (en) 2005-10-01
US6703411B2 (en) 2004-03-09
JP2003520267A (ja) 2003-07-02
CN1395558A (zh) 2003-02-05
AR027237A1 (es) 2003-03-19
RU2267486C2 (ru) 2006-01-10
MXPA02006431A (es) 2002-11-29
NO20023383D0 (no) 2002-07-12
YU52202A (sh) 2006-01-16
CZ20022465A3 (cs) 2002-10-16
NO20023383L (no) 2002-09-03

Similar Documents

Publication Publication Date Title
RU2160727C2 (ru) Бензоилгуанидины, способ их получения, промежуточное соединение для их получения, способ ингибирования и лекарственное средство
RU2214397C2 (ru) Ортозамещенные бензоилгуанидины и лекарственное средство на их основе
SI9500211A (en) Ortho-amino-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic as well as medicament containing them
SK10382002A3 (sk) Substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiv alebo diagnostík, a liečivo, ktoré ich obsahuje
SK93896A3 (en) 4-FLUOROALKYLSUBSTITUTED BENZOYLGUANIDINES, MANUFACTURING PROCESSìOF THEM, THEIR APPLICATION AS A MEDICAMENT OR DIAGNOSTIC AGENT, AS WELL AS MEDICAMENT CONTAINING THEM
KR100498799B1 (ko) 오르토-치환된벤조일구아니딘,이의제조방법및이를포함하는약제학적조성물
SK282356B6 (sk) Substituované 1-naftoylguanidíny, spôsob ich výroby, ich použitie ako liečiva alebo diagnostického prostriedku a liečivo, ktoré ich obsahuje
SI9500362A (en) Substituted benzoyl guanidines, process for the preparation thereof, use thereof as a medicine or as a diagnostic agent as well as a medicine containing them
CZ290027B6 (cs) Benzoylguanidin, jeho použití jako léčivo a léčivo tento benzoylguanidin obsahující
SK66497A3 (en) Bis-ortho-substituted benzoylguanidines, manufacturing process thereof, their us as a drug or diagnostic agent, as well as drug containing the same
SK23797A3 (en) Ortho-substituted benzoylguanidines, producing method, their use as a drug or diagnostic agent, as well as a drug containing the same
SK148796A3 (en) Diguanides of subsituted benzenedicarboxylic acids, preparation method thereof, their use as a drug or diagnostic agent, as well as a drug containing them
CZ97698A3 (cs) Ortho-substituované benzoylguanidiny, způsob jejich přípravy, léčivo, které je obsahuje, a jejich použití
SK283934B6 (sk) Orto-substituované benzoylguanidíny, spôsob ich prípravy, ich použitie ako liečiva a liečivá, ktoré ich obsahujú
MXPA97003871A (en) Benzoilguanidinas bis-orto-replaced, procedure for its preparation, its employment as a diagnostic medicine or agent, as well as a medication that conti

Legal Events

Date Code Title Description
FC9A Refused patent application